Obesity Drugs Could Get Lift From Part D Legislation, AMA Policy

Two events lead the way to greater coverage and reimbursement for obesity drugs: a bipartisan, bicameral bill that would remove Medicare Part D’s ban on covering obesity drugs and AMA’s recognition of obesity as a disease.

A major block to moving toward widespread coverage of obesity drugs by health plans would be removed through a bill introduced in the House and Senate June 19 with bipartisan support.

The bill, the “Treat and Reduce Obesity Act,” would remove the current statutory restriction on coverage of obesity drugs by...

More from United States

More from North America